調査レポート | • レポートコード：GIR-2104Z09066 • 出版社/出版日：GlobalInfoResearch / 2021年4月 ※2025年版があります。お問い合わせください。 • レポート形態：英文、PDF、130ページ • 納品方法：Eメール（納期：2~3日） • 産業分類：医療・医薬品 |
| Single User | ￥494,160 (USD3,480) | ▷ お問い合わせ |
| Multi User | ￥741,240 (USD5,220) | ▷ お問い合わせ |
| Corporate User | ￥988,320 (USD6,960) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 当調査資料では、メロキシカム薬のグローバル市場について調査・分析し、2021年から2026年までの市場予測をまとめております。メロキシカム薬の種類別市場規模（タブレット、カプセル）、用途別市場規模（成人用変形性関節症（OA）、成人用関節リウマチ（RA）、小児患者）、地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、中国、日本、東南アジア、南米、中東、アフリカなど）、市場動向、企業別販売量と市場シェア、販売チャネルなどの情報を掲載しています。 ・メロキシカム薬の市場概要 ・企業情報（企業概要、製品概要、販売量、価格、売上）：Boehringer-Ingelheim、TerSera Therapeutics、Iroko Pharmaceuticals、Apotex、Yung Shin Pharmaceutical、Breckenridge Pharmaceutical、Zydus Pharmaceuticals、Unichem Pharmaceuticals、Strides Pharma、Cipla、Dr. Reddy's Laboratories、Glenmark Pharmaceuticals、Teva、PuraCap Pharmaceutical、TARO、Lupin Pharmaceuticals、Aurobindo Pharma ・企業別市場シェア ・地域別市場分析2016年-2026年 ・種類別分析2016年-2026年：タブレット、カプセル ・用途別分析2016年-2026年：成人用変形性関節症（OA）、成人用関節リウマチ（RA）、小児患者 ・メロキシカム薬の北米市場規模2016年-2026年：アメリカ、カナダ、メキシコ ・メロキシカム薬のヨーロッパ市場規模2016年-2026年：ドイツ、イギリス、フランス、ロシア、イタリア ・メロキシカム薬のアジア市場規模2016年-2026年：中国、日本、韓国、インド、東南アジア、オーストラリア ・メロキシカム薬の南米市場規模2016年-2026年：ブラジル、アルゼンチン ・メロキシカム薬の中東・アフリカ市場規模2016年-2026年：サウジアラビア、トルコ、エジプト、南アフリカ ・販売チャネル、流通業者・代理店、顧客リスト ・調査の結果・結論 |
The Meloxicam Drug market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
According to our latest research, the global Meloxicam Drug size is estimated to be xx million in 2020 from USD xx million in 2019, with a change of XX% between 2019 and 2020. The global Meloxicam Drug market size is expected to grow at a CAGR of xx% for the next five years.
Market segmentation
Meloxicam Drug market is split by Type and by Application. For the period 2016-2026, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type, covers
Tablet
Capsule
Market segment by Application can be divided into
Osteoarthritis in Adults (OA)
Rheumatoid Arthritis in Adults (RA)
Pediatric Patients
The key market players for global Meloxicam Drug market are listed below:
Boehringer-Ingelheim
TerSera Therapeutics
Iroko Pharmaceuticals
Apotex
Yung Shin Pharmaceutical
Breckenridge Pharmaceutical
Zydus Pharmaceuticals
Unichem Pharmaceuticals
Strides Pharma
Cipla
Dr. Reddy’s Laboratories
Glenmark Pharmaceuticals
Teva
PuraCap Pharmaceutical
TARO
Lupin Pharmaceuticals
Aurobindo Pharma
Market segment by Region, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
1 Market Overview
1.1 Meloxicam Drug Introduction
1.2 Market Analysis by Type
1.2.1 Overview: Global Meloxicam Drug Revenue by Type: 2019 Versus 2021 Versus 2026
1.2.2 Tablet
1.2.3 Capsule
1.3 Market Analysis by Application
1.3.1 Overview: Global Meloxicam Drug Revenue by Application: 2019 Versus 2021 Versus 2026
1.3.2 Osteoarthritis in Adults (OA)
1.3.3 Rheumatoid Arthritis in Adults (RA)
1.3.4 Pediatric Patients
1.4 Global Meloxicam Drug Market Size & Forecast
1.4.1 Global Meloxicam Drug Sales in Value (2016-2026))
1.4.2 Global Meloxicam Drug Sales in Volume (2016-2026)
1.4.3 Global Meloxicam Drug Price by Type (2016-2026) & (USD/Unit)
1.5 Global Meloxicam Drug Production Capacity Analysis
1.5.1 Global Meloxicam Drug Total Production Capacity (2016-2026)
1.5.2 Global Meloxicam Drug Production Capacity by Geographic Region
1.6 Market Drivers, Restraints and Trends
1.6.1 Meloxicam Drug Market Drivers
1.6.2 Meloxicam Drug Market Restraints
1.6.3 Meloxicam Drug Trends Analysis
2 Manufacturers Profiles
2.1 Boehringer-Ingelheim
2.1.1 Boehringer-Ingelheim Details
2.1.2 Boehringer-Ingelheim Major Business
2.1.3 Boehringer-Ingelheim Meloxicam Drug Product and Services
2.1.4 Boehringer-Ingelheim Meloxicam Drug Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.2 TerSera Therapeutics
2.2.1 TerSera Therapeutics Details
2.2.2 TerSera Therapeutics Major Business
2.2.3 TerSera Therapeutics Meloxicam Drug Product and Services
2.2.4 TerSera Therapeutics Meloxicam Drug Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.3 Iroko Pharmaceuticals
2.3.1 Iroko Pharmaceuticals Details
2.3.2 Iroko Pharmaceuticals Major Business
2.3.3 Iroko Pharmaceuticals Meloxicam Drug Product and Services
2.3.4 Iroko Pharmaceuticals Meloxicam Drug Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.4 Apotex
2.4.1 Apotex Details
2.4.2 Apotex Major Business
2.4.3 Apotex Meloxicam Drug Product and Services
2.4.4 Apotex Meloxicam Drug Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.5 Yung Shin Pharmaceutical
2.5.1 Yung Shin Pharmaceutical Details
2.5.2 Yung Shin Pharmaceutical Major Business
2.5.3 Yung Shin Pharmaceutical Meloxicam Drug Product and Services
2.5.4 Yung Shin Pharmaceutical Meloxicam Drug Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.6 Breckenridge Pharmaceutical
2.6.1 Breckenridge Pharmaceutical Details
2.6.2 Breckenridge Pharmaceutical Major Business
2.6.3 Breckenridge Pharmaceutical Meloxicam Drug Product and Services
2.6.4 Breckenridge Pharmaceutical Meloxicam Drug Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.7 Zydus Pharmaceuticals
2.7.1 Zydus Pharmaceuticals Details
2.7.2 Zydus Pharmaceuticals Major Business
2.7.3 Zydus Pharmaceuticals Meloxicam Drug Product and Services
2.7.4 Zydus Pharmaceuticals Meloxicam Drug Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.8 Unichem Pharmaceuticals
2.8.1 Unichem Pharmaceuticals Details
2.8.2 Unichem Pharmaceuticals Major Business
2.8.3 Unichem Pharmaceuticals Meloxicam Drug Product and Services
2.8.4 Unichem Pharmaceuticals Meloxicam Drug Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.9 Strides Pharma
2.9.1 Strides Pharma Details
2.9.2 Strides Pharma Major Business
2.9.3 Strides Pharma Meloxicam Drug Product and Services
2.9.4 Strides Pharma Meloxicam Drug Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.10 Cipla
2.10.1 Cipla Details
2.10.2 Cipla Major Business
2.10.3 Cipla Meloxicam Drug Product and Services
2.10.4 Cipla Meloxicam Drug Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.11 Dr. Reddy’s Laboratories
2.11.1 Dr. Reddy’s Laboratories Details
2.11.2 Dr. Reddy’s Laboratories Major Business
2.11.3 Dr. Reddy’s Laboratories Meloxicam Drug Product and Services
2.11.4 Dr. Reddy’s Laboratories Meloxicam Drug Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.12 Glenmark Pharmaceuticals
2.12.1 Glenmark Pharmaceuticals Details
2.12.2 Glenmark Pharmaceuticals Major Business
2.12.3 Glenmark Pharmaceuticals Meloxicam Drug Product and Services
2.12.4 Glenmark Pharmaceuticals Meloxicam Drug Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.13 Teva
2.13.1 Teva Details
2.13.2 Teva Major Business
2.13.3 Teva Meloxicam Drug Product and Services
2.13.4 Teva Meloxicam Drug Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.14 PuraCap Pharmaceutical
2.14.1 PuraCap Pharmaceutical Details
2.14.2 PuraCap Pharmaceutical Major Business
2.14.3 PuraCap Pharmaceutical Meloxicam Drug Product and Services
2.14.4 PuraCap Pharmaceutical Meloxicam Drug Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.15 TARO
2.15.1 TARO Details
2.15.2 TARO Major Business
2.15.3 TARO Meloxicam Drug Product and Services
2.15.4 TARO Meloxicam Drug Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.16 Lupin Pharmaceuticals
2.16.1 Lupin Pharmaceuticals Details
2.16.2 Lupin Pharmaceuticals Major Business
2.16.3 Lupin Pharmaceuticals Meloxicam Drug Product and Services
2.16.4 Lupin Pharmaceuticals Meloxicam Drug Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.17 Aurobindo Pharma
2.17.1 Aurobindo Pharma Details
2.17.2 Aurobindo Pharma Major Business
2.17.3 Aurobindo Pharma Meloxicam Drug Product and Services
2.17.4 Aurobindo Pharma Meloxicam Drug Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
3 Meloxicam Drug Sales by Manufacturer
3.1 Global Meloxicam Drug Sales in Volume by Manufacturer (2019-2021e)
3.2 Global Meloxicam Drug Revenue by Manufacturer (2019-2021e)
3.3 Key Manufacturer Market Position in Meloxicam Drug
3.4 Market Concentration Rate
3.4.1 Top 3 Meloxicam Drug Manufacturer Market Share
3.4.2 Top 6 Meloxicam Drug Manufacturer Market Share
3.5 Global Meloxicam Drug Production Capacity by Company
3.6 Manufacturer by Geography: Head Office and Meloxicam Drug Production Site
3.7 New Entrant and Capacity Expansion Plans
3.8 Mergers & Acquisitions
4 Market Analysis by Region
4.1 Global Meloxicam Drug Market Size by Region
4.1.1 Global Meloxicam Drug Sales in Volume by Region (2016-2026)
4.1.2 Global Meloxicam Drug Revenue by Region (2016-2026)
4.2 North America Meloxicam Drug Revenue (2016-2026)
4.3 Europe Meloxicam Drug Revenue (2016-2026)
4.4 Asia-Pacific Meloxicam Drug Revenue (2016-2026)
4.5 South America Meloxicam Drug Revenue (2016-2026)
4.6 Middle East and Africa Meloxicam Drug Revenue (2016-2026)
5 Market Segment by Type
5.1 Global Meloxicam Drug Sales in Volume by Type (2016-2026)
5.2 Global Meloxicam Drug Revenue by Type (2016-2026)
5.3 Global Meloxicam Drug Price by Type (2016-2026)
6 Market Segment by Application
6.1 Global Meloxicam Drug Sales in Volume by Application (2016-2026)
6.2 Global Meloxicam Drug Revenue by Application (2016-2026)
6.3 Global Meloxicam Drug Price by Application (2016-2026)
7 North America by Country, by Type, and by Application
7.1 North America Meloxicam Drug Sales by Type (2016-2026)
7.2 North America Meloxicam Drug Sales by Application (2016-2026)
7.3 North America Meloxicam Drug Market Size by Country
7.3.1 North America Meloxicam Drug Sales in Volume by Country (2016-2026)
7.3.2 North America Meloxicam Drug Revenue by Country (2016-2026)
7.3.3 United States Market Size and Forecast (2016-2026)
7.3.4 Canada Market Size and Forecast (2016-2026)
7.3.5 Mexico Market Size and Forecast (2016-2026)
8 Europe by Country, by Type, and by Application
8.1 Europe Meloxicam Drug Sales by Type (2016-2026)
8.2 Europe Meloxicam Drug Sales by Application (2016-2026)
8.3 Europe Meloxicam Drug Market Size by Country
8.3.1 Europe Meloxicam Drug Sales in Volume by Country (2016-2026)
8.3.2 Europe Meloxicam Drug Revenue by Country (2016-2026)
8.3.3 Germany Market Size and Forecast (2016-2026)
8.3.4 France Market Size and Forecast (2016-2026)
8.3.5 United Kingdom Market Size and Forecast (2016-2026)
8.3.6 Russia Market Size and Forecast (2016-2026)
8.3.7 Italy Market Size and Forecast (2016-2026)
9 Asia-Pacific by Country, by Type, and by Application
9.1 Asia-Pacific Meloxicam Drug Sales by Type (2016-2026)
9.2 Asia-Pacific Meloxicam Drug Sales by Application (2016-2026)
9.3 Asia-Pacific Meloxicam Drug Market Size by Region
9.3.1 Asia-Pacific Meloxicam Drug Sales in Volume by Region (2016-2026)
9.3.2 Asia-Pacific Meloxicam Drug Revenue by Region (2016-2026)
9.3.3 China Market Size and Forecast (2016-2026)
9.3.4 Japan Market Size and Forecast (2016-2026)
9.3.5 Korea Market Size and Forecast (2016-2026)
9.3.6 India Market Size and Forecast (2016-2026)
9.3.7 Southeast Asia Market Size and Forecast (2016-2026)
9.3.8 Australia Market Size and Forecast (2016-2026)
10 South America by Country, by Type, and by Application
10.1 South America Meloxicam Drug Sales by Type (2016-2026)
10.2 South America Meloxicam Drug Sales by Application (2016-2026)
10.3 South America Meloxicam Drug Market Size by Country
10.3.1 South America Meloxicam Drug Sales in Volume by Country (2016-2026)
10.3.2 South America Meloxicam Drug Revenue by Country (2016-2026)
10.3.3 Brazil Market Size and Forecast (2016-2026)
10.3.4 Argentina Market Size and Forecast (2016-2026)
11 Middle East & Africa by Country, by Type, and by Application
11.1 Middle East & Africa Meloxicam Drug Sales by Type (2016-2026)
11.2 Middle East & Africa Meloxicam Drug Sales by Application (2016-2026)
11.3 Middle East & Africa Meloxicam Drug Market Size by Country
11.3.1 Middle East & Africa Meloxicam Drug Sales in Volume by Country (2016-2026)
11.3.2 Middle East & Africa Meloxicam Drug Revenue by Country (2016-2026)
11.3.3 Turkey Market Size and Forecast (2016-2026)
11.3.4 Egypt Market Size and Forecast (2016-2026)
11.3.5 Saudi Arabia Market Size and Forecast (2016-2026)
11.3.6 South Africa Market Size and Forecast (2016-2026)
12 Sales Channel, Distributors, Traders and Dealers
12.1 Sales Channel
12.1.1 Direct Marketing
12.1.2 Indirect Marketing
12.2 Meloxicam Drug Typical Distributors
12.3 Meloxicam Drug Typical Customers
13 Research Findings and Conclusion
14 Appendix
14.1 Methodology
14.2 Research Process and Data Source
14.3 Disclaimer
Table 1. Global Meloxicam Drug Revenue by Type, (USD Million), 2021-2026
Table 2. Global Meloxicam Drug Revenue by Application, (USD Million), 2021-2026
Table 3. Boehringer-Ingelheim Basic Information, Manufacturing Base and Competitors
Table 4. Boehringer-Ingelheim Major Business
Table 5. Boehringer-Ingelheim Meloxicam Drug Product and Services
Table 6. Boehringer-Ingelheim Meloxicam Drug Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 7. TerSera Therapeutics Basic Information, Manufacturing Base and Competitors
Table 8. TerSera Therapeutics Major Business
Table 9. TerSera Therapeutics Meloxicam Drug Product and Services
Table 10. TerSera Therapeutics Meloxicam Drug Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 11. Iroko Pharmaceuticals Basic Information, Manufacturing Base and Competitors
Table 12. Iroko Pharmaceuticals Major Business
Table 13. Iroko Pharmaceuticals Meloxicam Drug Product and Services
Table 14. Iroko Pharmaceuticals Meloxicam Drug Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 15. Apotex Basic Information, Manufacturing Base and Competitors
Table 16. Apotex Major Business
Table 17. Apotex Meloxicam Drug Product and Services
Table 18. Apotex Meloxicam Drug Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 19. Yung Shin Pharmaceutical Basic Information, Manufacturing Base and Competitors
Table 20. Yung Shin Pharmaceutical Major Business
Table 21. Yung Shin Pharmaceutical Meloxicam Drug Product and Services
Table 22. Yung Shin Pharmaceutical Meloxicam Drug Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 23. Breckenridge Pharmaceutical Basic Information, Manufacturing Base and Competitors
Table 24. Breckenridge Pharmaceutical Major Business
Table 25. Breckenridge Pharmaceutical Meloxicam Drug Product and Services
Table 26. Breckenridge Pharmaceutical Meloxicam Drug Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 27. Zydus Pharmaceuticals Basic Information, Manufacturing Base and Competitors
Table 28. Zydus Pharmaceuticals Major Business
Table 29. Zydus Pharmaceuticals Meloxicam Drug Product and Services
Table 30. Zydus Pharmaceuticals Meloxicam Drug Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 31. Unichem Pharmaceuticals Basic Information, Manufacturing Base and Competitors
Table 32. Unichem Pharmaceuticals Major Business
Table 33. Unichem Pharmaceuticals Meloxicam Drug Product and Services
Table 34. Unichem Pharmaceuticals Meloxicam Drug Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 35. Strides Pharma Basic Information, Manufacturing Base and Competitors
Table 36. Strides Pharma Major Business
Table 37. Strides Pharma Meloxicam Drug Product and Services
Table 38. Strides Pharma Meloxicam Drug Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 39. Cipla Basic Information, Manufacturing Base and Competitors
Table 40. Cipla Major Business
Table 41. Cipla Meloxicam Drug Product and Services
Table 42. Cipla Meloxicam Drug Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 43. Dr. Reddy's Laboratories Basic Information, Manufacturing Base and Competitors
Table 44. Dr. Reddy's Laboratories Major Business
Table 45. Dr. Reddy's Laboratories Meloxicam Drug Product and Services
Table 46. Dr. Reddy's Laboratories Meloxicam Drug Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 47. Glenmark Pharmaceuticals Basic Information, Manufacturing Base and Competitors
Table 48. Glenmark Pharmaceuticals Major Business
Table 49. Glenmark Pharmaceuticals Meloxicam Drug Product and Services
Table 50. Glenmark Pharmaceuticals Meloxicam Drug Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 51. Teva Basic Information, Manufacturing Base and Competitors
Table 52. Teva Major Business
Table 53. Teva Meloxicam Drug Product and Services
Table 54. Teva Meloxicam Drug Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 55. PuraCap Pharmaceutical Basic Information, Manufacturing Base and Competitors
Table 56. PuraCap Pharmaceutical Major Business
Table 57. PuraCap Pharmaceutical Meloxicam Drug Product and Services
Table 58. PuraCap Pharmaceutical Meloxicam Drug Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 59. TARO Basic Information, Manufacturing Base and Competitors
Table 60. TARO Major Business
Table 61. TARO Meloxicam Drug Product and Services
Table 62. TARO Meloxicam Drug Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 63. Lupin Pharmaceuticals Basic Information, Manufacturing Base and Competitors
Table 64. Lupin Pharmaceuticals Major Business
Table 65. Lupin Pharmaceuticals Meloxicam Drug Product and Services
Table 66. Lupin Pharmaceuticals Meloxicam Drug Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 67. Aurobindo Pharma Basic Information, Manufacturing Base and Competitors
Table 68. Aurobindo Pharma Major Business
Table 69. Aurobindo Pharma Meloxicam Drug Product and Services
Table 70. Aurobindo Pharma Meloxicam Drug Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 71. Global Meloxicam Drug Sales by Manufacturer (2019-2021e) & (K Units)
Table 72. Global Meloxicam Drug Revenue by Manufacturer (2019-2021e) & (USD Million)
Table 73. Market Position of Manufacturers in Meloxicam Drug, (Tier 1, Tier 2, and Tier 3), Based on Revenue in 2020
Table 74. Global Meloxicam Drug Production Capacity by Company, (K Units): 2020 VS 2021
Table 75. Head Office and Meloxicam Drug Production Site of Key Manufacturer
Table 76. Global Meloxicam Drug Sales by Region (2016-2021e) & (K Units)
Table 77. Global Meloxicam Drug Sales by Region (2021-2026) & (K Units)
Table 78. Global Meloxicam Drug Revenue by Region (2016-2021e) & (USD Million)
Table 79. Global Meloxicam Drug Revenue by Region (2021-2026) & (USD Million)
Table 80. Global Meloxicam Drug Sales by Type (2016-2021e) & (K Units)
Table 81. Global Meloxicam Drug Sales by Type (2021-2026) & (K Units)
Table 82. Global Meloxicam Drug Revenue by Type (2016-2021e) & (USD Million)
Table 83. Global Meloxicam Drug Revenue by Type (2021-2026) & (USD Million)
Table 84. Global Meloxicam Drug Price by Type (2016-2021e) & (USD/Unit)
Table 85. Global Meloxicam Drug Price by Type (2021-2026) & (USD/Unit)
Table 86. Global Meloxicam Drug Sales by Application (2016-2021e) & (K Units)
Table 87. Global Meloxicam Drug Sales by Application (2021-2026) & (K Units)
Table 88. Global Meloxicam Drug Revenue by Application (2016-2021e) & (USD Million)
Table 89. Global Meloxicam Drug Revenue by Application (2021-2026) & (USD Million)
Table 90. Global Meloxicam Drug Price by Application (2016-2021e) & (USD/Unit)
Table 91. Global Meloxicam Drug Price by Application (2021-2026) & (USD/Unit)
Table 92. North America Meloxicam Drug Sales by Country (2016-2021e) & (K Units)
Table 93. North America Meloxicam Drug Sales by Country (2021-2026) & (K Units)
Table 94. North America Meloxicam Drug Revenue by Country (2016-2021e) & (USD Million)
Table 95. North America Meloxicam Drug Revenue by Country (2021-2026) & (USD Million)
Table 96. North America Meloxicam Drug Sales by Type (2016-2021e) & (K Units)
Table 97. North America Meloxicam Drug Sales by Type (2021-2026) & (K Units)
Table 98. North America Meloxicam Drug Sales by Application (2016-2021e) & (K Units)
Table 99. North America Meloxicam Drug Sales by Application (2021-2026) & (K Units)
Table 100. Europe Meloxicam Drug Sales by Country (2016-2021e) & (K Units)
Table 101. Europe Meloxicam Drug Sales by Country (2021-2026) & (K Units)
Table 102. Europe Meloxicam Drug Revenue by Country (2016-2021e) & (USD Million)
Table 103. Europe Meloxicam Drug Revenue by Country (2021-2026) & (USD Million)
Table 104. Europe Meloxicam Drug Sales by Type (2016-2021e) & (K Units)
Table 105. Europe Meloxicam Drug Sales by Type (2021-2026) & (K Units)
Table 106. Europe Meloxicam Drug Sales by Application (2016-2021e) & (K Units)
Table 107. Europe Meloxicam Drug Sales by Application (2021-2026) & (K Units)
Table 108. Asia-Pacific Meloxicam Drug Sales by Region (2016-2021e) & (K Units)
Table 109. Asia-Pacific Meloxicam Drug Sales by Region (2021-2026) & (K Units)
Table 110. Asia-Pacific Meloxicam Drug Revenue by Region (2016-2021e) & (USD Million)
Table 111. Asia-Pacific Meloxicam Drug Revenue by Region (2021-2026) & (USD Million)
Table 112. Asia-Pacific Meloxicam Drug Sales by Type (2016-2021e) & (K Units)
Table 113. Asia-Pacific Meloxicam Drug Sales by Type (2021-2026) & (K Units)
Table 114. Asia-Pacific Meloxicam Drug Sales by Application (2016-2021e) & (K Units)
Table 115. Asia-Pacific Meloxicam Drug Sales by Application (2021-2026) & (K Units)
Table 116. South America Meloxicam Drug Sales by Country (2016-2021e) & (K Units)
Table 117. South America Meloxicam Drug Sales by Country (2021-2026) & (K Units)
Table 118. South America Meloxicam Drug Revenue by Country (2016-2021e) & (USD Million)
Table 119. South America Meloxicam Drug Revenue by Country (2021-2026) & (USD Million)
Table 120. South America Meloxicam Drug Sales by Type (2016-2021e) & (K Units)
Table 121. South America Meloxicam Drug Sales by Type (2021-2026) & (K Units)
Table 122. South America Meloxicam Drug Sales by Application (2016-2021e) & (K Units)
Table 123. South America Meloxicam Drug Sales by Application (2021-2026) & (K Units)
Table 124. Middle East & Africa Meloxicam Drug Sales by Country (2016-2021e) & (K Units)
Table 125. Middle East & Africa Meloxicam Drug Sales by Country (2021-2026) & (K Units)
Table 126. Middle East & Africa Meloxicam Drug Revenue by Country (2016-2021e) & (USD Million)
Table 127. Middle East & Africa Meloxicam Drug Revenue by Country (2021-2026) & (USD Million)
Table 128. Middle East & Africa Meloxicam Drug Sales by Type (2016-2021e) & (K Units)
Table 129. Middle East & Africa Meloxicam Drug Sales by Type (2021-2026) & (K Units)
Table 130. Middle East & Africa Meloxicam Drug Sales by Application (2016-2021e) & (K Units)
Table 131. Middle East & Africa Meloxicam Drug Sales by Application (2021-2026) & (K Units)
Table 132. Direct Channel Pros & Cons
Table 133. Indirect Channel Pros & Cons
Table 134. Meloxicam Drug Typical Distributors
Table 135. Meloxicam Drug Typical Customers
List of Figures
Figure 1. Meloxicam Drug Picture
Figure 2. Global Meloxicam Drug Sales Market Share by Type in 2020
Figure 3. Tablet
Figure 4. Capsule
Figure 5. Global Meloxicam Drug Sales Market Share by Application in 2020
Figure 6. Osteoarthritis in Adults (OA)
Figure 7. Rheumatoid Arthritis in Adults (RA)
Figure 8. Pediatric Patients
Figure 9. Global Meloxicam Drug Market Size, (USD Million) & (K Units): 2020 VS 2021 VS 2026
Figure 10. Global Meloxicam Drug Market Size and Forecast (2016-2026) & (USD Million)
Figure 11. United States Meloxicam Drug Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 12. Canada Meloxicam Drug Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 13. Mexico Meloxicam Drug Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 14. Germany Meloxicam Drug Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 15. France Meloxicam Drug Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 16. United Kingdom Meloxicam Drug Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 17. Russia Meloxicam Drug Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 18. Italy Meloxicam Drug Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 19. China Meloxicam Drug Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 20. Japan Meloxicam Drug Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 21. Korea Meloxicam Drug Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 22. India Meloxicam Drug Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 23. Southeast Asia Meloxicam Drug Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 24. Australia Meloxicam Drug Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 25. Brazil Meloxicam Drug Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 26. Egypt Meloxicam Drug Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 27. Saudi Arabia Meloxicam Drug Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 28. South Africa Meloxicam Drug Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 29. Turkey Meloxicam Drug Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 30. Global Meloxicam Drug Sales (2016-2026) & (K Units)
Figure 31. Global Meloxicam Drug Production Capacity (2016-2026) & (K Units)
Figure 32. Global Meloxicam Drug Production Capacity by Geographic Region: 2020 VS 2021
Figure 33. Meloxicam Drug Market Drivers
Figure 34. Meloxicam Drug Market Restraints
Figure 35. Meloxicam Drug Market Trends
Figure 36. Global Meloxicam Drug Sales Market Share by Manufacturer in 2020
Figure 37. Global Meloxicam Drug Revenue Market Share by Manufacturer in 2020
Figure 38. Meloxicam Drug Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
Figure 39. Top 3 Meloxicam Drug Manufacturer (Revenue) Market Share in 2020
Figure 40. Top 6 Meloxicam Drug Manufacturer (Revenue) Market Share in 2020
Figure 41. Global Meloxicam Drug Sales Market Share by Region (2016-2026)
Figure 42. Global Meloxicam Drug Revenue Market Share by Region (2016-2026)
Figure 43. North America Meloxicam Drug Revenue (2016-2026) & (USD Million)
Figure 44. Europe Meloxicam Drug Revenue (2016-2026) & (USD Million)
Figure 45. Asia-Pacific Meloxicam Drug Revenue (2016-2026) & (USD Million)
Figure 46. South America Meloxicam Drug Revenue (2016-2026) & (USD Million)
Figure 47. Middle East & Africa Meloxicam Drug Revenue (2016-2026) & (USD Million)
Figure 48. Global Meloxicam Drug Sales Market Share by Type (2016-2026)
Figure 49. Global Meloxicam Drug Revenue Market Share by Type (2016-2026)
Figure 50. Global Meloxicam Drug Price by Type (2016-2026) & (USD/Unit)
Figure 51. Global Meloxicam Drug Sales Market Share by Application (2016-2026)
Figure 52. Global Meloxicam Drug Revenue Market Share by Application (2016-2026)
Figure 53. Global Meloxicam Drug Price by Application (2016-2026) & (USD/Unit)
Figure 54. North America Meloxicam Drug Sales Market Share by Country (2016-2026)
Figure 55. North America Meloxicam Drug Revenue Market Share by Country (2016-2026)
Figure 56. North America Meloxicam Drug Sales Market Share by Type (2016-2026)
Figure 57. North America Meloxicam Drug Sales Market Share by Application (2016-2026)
Figure 58. Europe Meloxicam Drug Sales Market Share by Country (2016-2026)
Figure 59. Europe Meloxicam Drug Revenue Market Share by Country (2016-2026)
Figure 60. Europe Meloxicam Drug Sales Market Share by Type (2016-2026)
Figure 61. Europe Meloxicam Drug Sales Market Share by Application (2016-2026)
Figure 62. Asia-Pacific Meloxicam Drug Sales Market Share by Region (2016-2026)
Figure 63. Asia-Pacific Meloxicam Drug Revenue Market Share by Region (2016-2026)
Figure 64. Asia-Pacific Meloxicam Drug Sales Market Share by Region (2016-2026)
Figure 65. Asia-Pacific Meloxicam Drug Sales Market Share by Application (2016-2026)
Figure 66. South America Meloxicam Drug Sales Market Share by Country (2016-2026)
Figure 67. South America Meloxicam Drug Revenue Market Share by Country (2016-2026)
Figure 68. South America Meloxicam Drug Sales Market Share by Type (2016-2026)
Figure 69. South America Meloxicam Drug Sales Market Share by Application (2016-2026)
Figure 70. Middle East & Africa Meloxicam Drug Sales Market Share by Country (2016-2026)
Figure 71. Middle East & Africa Meloxicam Drug Revenue Market Share by Country (2016-2026)
Figure 72. Middle East & Africa Meloxicam Drug Sales Market Share by Type (2016-2026)
Figure 73. Middle East & Africa Meloxicam Drug Sales Market Share by Application (2016-2026)
Figure 74. Sales Channel: Direct Channel vs Indirect Channel
Figure 75. Methodology
Figure 76. Research Process and Data Source
世界の股関節変形性股関節症鎮痛剤市場 2021：企業別、地域別、種類・用途別 The Hip Osteoarthritis Pain Drug market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade re…- 世界のタミフル（オセルタミビル）薬市場 2021：企業別、地域別、種類・用途別 The Tamiflu (Oseltamivir) Drug market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regu…
- 世界のアレルギー性鼻炎治療薬市場規模・現状・予測（2021年-2027年） Market Analysis and Insights: Global Allergy Rhinitis Drug Market The global Allergy Rhinitis Drug market size is projected to reach US$ XX million by 2026, from US$ XX million in 2019, at a CAGR of XX% during 2021-2026. With industry-standard accuracy in analysis and high data integrity, the report…
- 世界の小売薬市場規模・現状・予測（2021年-2027年） A drug is any substance (other than food that provides nutritional support) that, when inhaled, injected, smoked, consumed, absorbed via a patch on the skin, or dissolved under the tongue causes a temporary physiological (and often psychological) change in the body. Increasing industry share of Asia…
- 世界の特殊医薬品流通市場規模・現状・予測（2021年-2027年） Specialty Drug Distribution is a link of pharmaceutical logistics; it distributes Specialty Drug to consumers relying on certain logistics equipment, technology and logistics management information system. Specialty drugs play an increasingly important role in the treatment of chronic conditions suc…